课题基金 / 基金详情

Administrative Supplement to Regulators of retinal metabolism in healthy and degenerating retinas

Administrative Supplement to Regulators of retinal metabolism in healthy and degenerating retinas
健康和退化视网膜视网膜代谢调节剂的行政补充
批准号:
10361928
负责人:
John D Ash
金额:
$13.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-01 至 2025-06-30

项目摘要

项目成果

John D Ash的其他基金

相似基金

相关文献

中文摘要
翻译
摘要: 视网膜有很高的代谢活性,视网膜退行性变与 线粒体功能障碍、代谢失调和毒性氧化损伤。然而, 关于新陈代谢在正常情况下是如何维持的,或者新陈代谢是如何失调的,我们知之甚少 在退化的视网膜中。AMPK(AMP-激活蛋白激酶)是一种重要的代谢调节因子 在高度代谢的组织中,是调节光感受器新陈代谢的候选分子,其 在这项拟议的项目中,将严格研究视网膜新陈代谢中的作用,使用 功能和丧失功能的方法。过氧化物酶体增殖物激活受体γ 辅活化子-α(pgc-1α)和β(pgc-1β)是线粒体生物发生的关键调节因子。 AMPK是PGC-1的重要调节因子 活动。我们在这项研究中的目标是确定AMPK和PGC-1在视网膜中的作用 光感受器。
英文摘要
Abstract: The retina hashigh metabolic activity,and retinal degenerations have been associated with mitochondrial dysfunction, dysregulation of metabolism, and toxic oxidative damage. However, little is known about how metabolism is maintained under normal conditions or is dysregulated in degenerating retinas. AMPK (AMP-activated protein kinase)is a key regulator of metabolism in highly metabolic tissues and is a candidate to regulate metabolism in photoreceptors, and its role in retinal metabolism will be rigorously studied in this proposed project using both gain-of- function and loss-of-function approaches. Peroxisome proliferator-activated receptor gamma coactivator-alpha (PGC-1α) and beta (PGC-1β) are key regulators of mitochondrialbiogenesis. Adenosine monophosphate dependent kinase (AMPK) is an important regulator of PGC-1 activity. Our goal in this study isto determine the rolesof AMPK and PGC-1activity in retinal photoreceptors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Retinal Degeneration Conference
Dual Targeting Mitochondria and GPCR in Retinal Protection
  • 批准号:
    10383538
  • 项目类别:
  • 资助金额:
    $25.57万
  • 财政年份:
    2022
  • 负责人:
    John D Ash
  • 依托单位:
Transcriptional control of stress-induced resistance to retinal degeneration
  • 批准号:
    10477262
  • 项目类别:
  • 资助金额:
    $37.22万
  • 财政年份:
    2021
  • 负责人:
    John D Ash
  • 依托单位:
Transcriptional control of stress-induced resistance to retinal degeneration
  • 批准号:
    10296291
  • 项目类别:
  • 资助金额:
    $38.37万
  • 财政年份:
    2021
  • 负责人:
    John D Ash
  • 依托单位:
海外基金